NASDAQ: CMND
Clearmind Medicine Revenue

Clearmind Medicine revenue was $0.00 for the trailing 12 months ending Jan 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Jan 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Oct 31, 2024, CMND annual revenue was $0.0, with N/A growth year-over-year.

CMND revenue history

Current Revenue
$0.0
Current Earnings
-$5.0M
Current Profit Margin
0%

Be the first to know when CMND announces revenue.

CMND Revenue History By Year

CMND Yearly RevenueCMND RevenueCMND ChangeCMND Revenue Growth
2024-10-31$0.00N/AN/A
2023-10-31$0.00N/AN/A
2022-10-31$0.00N/AN/A
2021-10-31$0.00N/AN/A
2020-10-31$0.00N/AN/A

1 of 1

Clearmind Medicine Revenue FAQ

What was CMND's revenue last quarter?

Clearmind Medicine (NASDAQ: CMND) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Clearmind Medicine's revenue was $0.00.

What was Clearmind Medicine's revenue in 2024?

Clearmind Medicine's annual revenue for the twelve months ending Oct 31, 2024 was $0.00, a N/A decrease year over year.

How much does Clearmind Medicine make in a day?

Based on Clearmind Medicine annual revenue for the past four years, CMND makes an average of $0.00 per day.

What was Clearmind Medicine's annual revenue growth in the past year?

As of Q2 2025, Clearmind Medicine's revenue has grown null year over year. Clearmind Medicine's revenue in the past year totaled $0.00.

How much does Clearmind Medicine make in a year?

Clearmind Medicine's revenue by year for the past four years is:
  • Clearmind Medicine's revenue for the twelve months ending Oct 31, 2024 was $0.00, a N/A decrease year over year.
  • Clearmind Medicine's annual revenue for Oct 31, 2023 was $0.00, a N/A decrease from 2022.
  • Clearmind Medicine's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Clearmind Medicine's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.